A series of pyranonaphthoquinone derivatives possessing structural features present in both natural products annulin B and exiguamine A have been shown to exhibit low micromolar inhibition of indoleamine 2,3-dioxygenase-1 (IDO-1). These inhibitors retain activity against the enzyme in a cellular context with an approximate one-log loss of dose potency against IDO-1 in cells. One particular analogue, triazole 8 shows good inhibition of IDO-1 along with little loss of cell viability at low drug concentrations. These results have extended the naphthoquinone series of novel IDO-1 inhibitors based on lead compounds from nature.10 page(s
International audienceIndoleamine 2,3-dioxygenase (IDO1) and tryptophane 2,3-dioxygenase (TDO) are t...
Indoleamine 2,3-dioxygenase 2 (IDO2) is a potential therapeutic target for the treatment of diseases...
The heme-containing enzymes indoleamine 2,3-dioxygenase-1 (IDO-1) and IDO-2 catalyze the conversion ...
Aseries of pyranonaphthoquinone derivatives possessing structural features present in both natural p...
There is great interest in developing small molecules agents capable of reversing tumor immune escap...
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan degradation enzyme that is emerging as an importan...
One potentially attractive approach to cancer therapy is to recruit the body’s own immune system to ...
Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the rate-limiting step in the kynurenine pathway of t...
Tsitsikammamines are marine alkaloids whose structure is based on the pyrroloiminoquinone scaffold. ...
Tsitsikammamines are marine alkaloids whose structure is based on the pyrroloiminoquinone scaffold. ...
Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metab...
Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metab...
Indoleamine 2,3-dioxygenase 2 (IDO2) is a potential therapeutic target for the treatment of diseases...
Indoleamine 2,3-dioxygenase 1 (IDO1) is an intracellular monomeric heme-containing enzyme that catal...
Current research describing therole of indoleamine 2,3-dioxygenase (IDO) and its mechanism of action...
International audienceIndoleamine 2,3-dioxygenase (IDO1) and tryptophane 2,3-dioxygenase (TDO) are t...
Indoleamine 2,3-dioxygenase 2 (IDO2) is a potential therapeutic target for the treatment of diseases...
The heme-containing enzymes indoleamine 2,3-dioxygenase-1 (IDO-1) and IDO-2 catalyze the conversion ...
Aseries of pyranonaphthoquinone derivatives possessing structural features present in both natural p...
There is great interest in developing small molecules agents capable of reversing tumor immune escap...
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan degradation enzyme that is emerging as an importan...
One potentially attractive approach to cancer therapy is to recruit the body’s own immune system to ...
Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the rate-limiting step in the kynurenine pathway of t...
Tsitsikammamines are marine alkaloids whose structure is based on the pyrroloiminoquinone scaffold. ...
Tsitsikammamines are marine alkaloids whose structure is based on the pyrroloiminoquinone scaffold. ...
Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metab...
Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metab...
Indoleamine 2,3-dioxygenase 2 (IDO2) is a potential therapeutic target for the treatment of diseases...
Indoleamine 2,3-dioxygenase 1 (IDO1) is an intracellular monomeric heme-containing enzyme that catal...
Current research describing therole of indoleamine 2,3-dioxygenase (IDO) and its mechanism of action...
International audienceIndoleamine 2,3-dioxygenase (IDO1) and tryptophane 2,3-dioxygenase (TDO) are t...
Indoleamine 2,3-dioxygenase 2 (IDO2) is a potential therapeutic target for the treatment of diseases...
The heme-containing enzymes indoleamine 2,3-dioxygenase-1 (IDO-1) and IDO-2 catalyze the conversion ...